Logo image of ABLD.PA

ABL DIAGNOSTICS (ABLD.PA) Stock Fundamental Analysis

EPA:ABLD - Euronext Paris - Matif - FR001400AHX6 - Common Stock - Currency: EUR

5.45  0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ABLD. ABLD was compared to 16 industry peers in the Trading Companies & Distributors industry. While ABLD seems to be doing ok healthwise, there are quite some concerns on its profitability. ABLD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ABLD had positive earnings in the past year.
ABLD had a positive operating cash flow in the past year.
ABLD had positive earnings in 4 of the past 5 years.
ABLD had negative operating cash flow in 4 of the past 5 years.
ABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M

1.2 Ratios

ABLD's Return On Assets of 1.36% is in line compared to the rest of the industry. ABLD outperforms 43.75% of its industry peers.
With a Return On Equity value of 2.70%, ABLD perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
Industry RankSector Rank
ROA 1.36%
ROE 2.7%
ROIC N/A
ROA(3y)3.32%
ROA(5y)3.14%
ROE(3y)6.99%
ROE(5y)5.41%
ROIC(3y)N/A
ROIC(5y)N/A
ABLD.PA Yearly ROA, ROE, ROICABLD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

The Profit Margin of ABLD (3.13%) is better than 62.50% of its industry peers.
ABLD does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 3.13%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABLD.PA Yearly Profit, Operating, Gross MarginsABLD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400

More info and screens

6

2. Health

2.1 Basic Checks

ABLD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ABLD remains at a similar level compared to 1 year ago.
ABLD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ABLD has an improved debt to assets ratio.
ABLD.PA Yearly Shares OutstandingABLD.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ABLD.PA Yearly Total Debt VS Total AssetsABLD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

ABLD has an Altman-Z score of 8.78. This indicates that ABLD is financially healthy and has little risk of bankruptcy at the moment.
ABLD has a better Altman-Z score (8.78) than 100.00% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that ABLD is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.26, ABLD is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 8.78
ROIC/WACCN/A
WACC7.79%
ABLD.PA Yearly LT Debt VS Equity VS FCFABLD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

2.3 Liquidity

ABLD has a Current Ratio of 2.06. This indicates that ABLD is financially healthy and has no problem in meeting its short term obligations.
ABLD has a better Current ratio (2.06) than 62.50% of its industry peers.
ABLD has a Quick Ratio of 1.92. This is a normal value and indicates that ABLD is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ABLD (1.92) is better than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.06
Quick Ratio 1.92
ABLD.PA Yearly Current Assets VS Current LiabilitesABLD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

5

3. Growth

3.1 Past

ABLD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 420.59%, which is quite impressive.
ABLD shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -48.36% yearly.
Looking at the last year, ABLD shows a decrease in Revenue. The Revenue has decreased by -5.03% in the last year.
EPS 1Y (TTM)420.59%
EPS 3Y-48.36%
EPS 5YN/A
EPS Q2Q%134.78%
Revenue 1Y (TTM)-5.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.02%

3.2 Future

The Earnings Per Share is expected to grow by 41.42% on average over the next years. This is a very strong growth
Based on estimates for the next years, ABLD will show a very strong growth in Revenue. The Revenue will grow by 41.75% on average per year.
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year34.37%
Revenue Next 2Y41.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
ABLD.PA Yearly Revenue VS EstimatesABLD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
ABLD.PA Yearly EPS VS EstimatesABLD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.02 0.04 0.06

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 272.50, ABLD can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of ABLD indicates a slightly more expensive valuation: ABLD is more expensive than 68.75% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.34, ABLD is valued quite expensively.
Based on the Price/Forward Earnings ratio of 89.05, the valuation of ABLD can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ABLD is on the same level as its industry peers.
ABLD is valuated expensively when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 272.5
Fwd PE 89.05
ABLD.PA Price Earnings VS Forward Price EarningsABLD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABLD.PA Per share dataABLD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as ABLD's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)2.73
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.93%, ABLD is not a good candidate for dividend investing.
ABLD's Dividend Yield is comparable with the industry average which is at 2.75.
Compared to an average S&P500 Dividend Yield of 2.40, ABLD's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.93%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ABLD.PA Yearly Dividends per shareABLD.PA Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.02 0.03 0.04

5.3 Sustainability

DPN/A
EPS Next 2Y41.42%
EPS Next 3YN/A
ABLD.PA Yearly Income VS Free CF VS DividendABLD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M

More info and screens

ABL DIAGNOSTICS

EPA:ABLD (6/19/2025, 7:00:00 PM)

5.45

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners99.64%
Ins Owner ChangeN/A
Market Cap87.80M
Analysts85.71
Price Target6.28 (15.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.93%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 272.5
Fwd PE 89.05
P/S 14.88
P/FCF N/A
P/OCF 110.5
P/B 12.82
P/tB 20.9
EV/EBITDA N/A
EPS(TTM)0.02
EY0.37%
EPS(NY)0.06
Fwd EY1.12%
FCF(TTM)0
FCFYN/A
OCF(TTM)0.05
OCFY0.91%
SpS0.37
BVpS0.43
TBVpS0.26
PEG (NY)2.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.36%
ROE 2.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.13%
GM N/A
FCFM N/A
ROA(3y)3.32%
ROA(5y)3.14%
ROE(3y)6.99%
ROE(5y)5.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 13.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.06
Quick Ratio 1.92
Altman-Z 8.78
F-Score5
WACC7.79%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)420.59%
EPS 3Y-48.36%
EPS 5YN/A
EPS Q2Q%134.78%
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.02%
Revenue Next Year34.37%
Revenue Next 2Y41.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-76.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year789.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y61.93%
OCF growth 3YN/A
OCF growth 5YN/A